Pharmaceutical companies:
Improve your patient support program
Looking for a better patient experience that drives brand performance?
AllazoHealth’s artificial intelligence engine accurately predicts patient non-adherence. The result: personalized engagements that deliver increased persistence and better patient outcomes for pharmaceutical companies.
By targeting individual patients based on their historical behavior and unique attributes, the AllazoHealth AI engine predicts the most effective engagement, personalized by channel, content, and timing.
And our artificial intelligence engine gets smarter over time, so your patient support program will continuously improve and deliver more value.
Benefits of AI-powered patient engagement
Supports patient health
Optimizes patient experience
Promotes brand loyalty
Learn how AllazoHealth used AI to optimize patient engagement in a leading pharmaceutical company’s patient support program.
Senior medication adherence: the growing problem
By the year 2030 the entire Baby Boomer generation will be age 65 or older. This growing number of senior Boomers will challenge the health…
Advances in patient interventions: How to manage complexity
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels…
The challenge of mental health drug non-adherence
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people…